SCHEMBL21708473

SCHEMBL21708473

CCCC(F)OC(=O)CCC(C#N)c1ccccc1C(F)(F)F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.34
KDM4E B2RXH2 1/20 0.34
KMT2A Q03164 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C9 P11712 2/20 0.33
TSHR P16473 2/20 0.33
CYP2C19 P33261 2/20 0.33
F2R P25116 1/20 0.33
ALDH1A1 P00352 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
EPHX2 P34913 1/20 0.32
PPARG P37231 1/20 0.32
SLC6A4 P31645 1/20 0.32
KCNK3 O14649 1/20 0.32
KCNK9 Q9NPC2 1/20 0.32
MAPK1 P28482 2/20 0.32
POLB P06746 1/20 0.32
ACP3 P15309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21708746 0.90 CNR2 (0.34) CNR2KDM4EKMT2ACYP1A2CYP3A4
SCHEMBL21708548 0.85 MEN1 (0.35) KMT2AALDH1A1TDP1SLC6A4MAPK1
SCHEMBL21708707 0.85 CCR1 (0.36) CNR2KDM4EKMT2ACYP3A4ALDH1A1
SCHEMBL21708466 0.85 F2R (0.36) F2RPPARGKCNK3KCNK9
SCHEMBL21708512 0.84 CCR1 (0.36) KDM4EKMT2ACYP1A2CYP3A4CYP2C9
SCHEMBL21708544 0.84 POLB (0.38) KMT2ATSHRPPARGPOLBHPGD
SCHEMBL21708524 0.84 CTSS (0.32) F2REPHX2
SCHEMBL194920 0.83 APP (0.41) CNR2KDM4EKMT2ACYP1A2TSHR
SCHEMBL28776287 0.83 CTSK (0.37) CNR2KDM4ECYP1A2CYP3A4CYP2C9
SCHEMBL21708654 0.82 MEN1 (0.38) KDM4EKMT2ATSHRPPARGKCNK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed
EP-3609870-A1 SUBSTITUTED N-ARYLETHYL-2-AMINOQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed